Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Monitoring Asthma Treatment Using Exhaled Nitric Oxide (NOASTHMA)

This study has been completed.
Merck Sharp & Dohme Corp.
Aerocrine AB
Information provided by:
University Hospital, Antwerp Identifier:
First received: November 21, 2007
Last updated: June 15, 2011
Last verified: November 2007
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2009
  Estimated Primary Completion Date: No date given
Publications automatically indexed to this study by Identifier (NCT Number):